Business Description
Aptamer Sciences Inc
ISIN : KR7291650000
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.64 | |||||
Debt-to-EBITDA | -0.87 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 0.62 | |||||
Beneish M-Score | 9.09 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.9 | |||||
3-Year EBITDA Growth Rate | -43.6 | |||||
3-Year EPS without NRI Growth Rate | -41.8 | |||||
3-Year FCF Growth Rate | -39.4 | |||||
3-Year Book Growth Rate | -24.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.97 | |||||
9-Day RSI | 54.41 | |||||
14-Day RSI | 50.33 | |||||
6-1 Month Momentum % | -22.74 | |||||
12-1 Month Momentum % | -23.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.49 | |||||
Quick Ratio | 1.49 | |||||
Days Inventory | 467.39 | |||||
Days Sales Outstanding | 25.49 | |||||
Days Payable | 63.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -9.06 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.77 | |||||
Operating Margin % | -4469.3 | |||||
Net Margin % | -6237.56 | |||||
FCF Margin % | -5339.22 | |||||
ROE % | -71.18 | |||||
ROA % | -37.52 | |||||
ROIC % | -61.13 | |||||
ROC (Joel Greenblatt) % | -128.11 | |||||
ROCE % | -34.69 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 220.84 | |||||
PB Ratio | 3.67 | |||||
Price-to-Tangible-Book | 3.67 | |||||
EV-to-EBIT | -3.28 | |||||
EV-to-EBITDA | -3.43 | |||||
EV-to-Revenue | 151.21 | |||||
EV-to-FCF | -2.83 | |||||
Price-to-Net-Current-Asset-Value | 8.54 | |||||
Earnings Yield (Greenblatt) % | -30.49 | |||||
FCF Yield % | -24.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aptamer Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 216.066 | ||
EPS (TTM) (â‚©) | -793.581 | ||
Beta | 0.03 | ||
Volatility % | 37.95 | ||
14-Day RSI | 50.33 | ||
14-Day ATR (â‚©) | 185.212567 | ||
20-Day SMA (â‚©) | 2764.5 | ||
12-1 Month Momentum % | -23.17 | ||
52-Week Range (â‚©) | 2400 - 6080 | ||
Shares Outstanding (Mil) | 16.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aptamer Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aptamer Sciences Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Aptamer Sciences Inc Frequently Asked Questions
What is Aptamer Sciences Inc(XKRX:291650)'s stock price today?
When is next earnings date of Aptamer Sciences Inc(XKRX:291650)?
Does Aptamer Sciences Inc(XKRX:291650) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |